Raymond James & Associates 23and Me Holding Co. Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

A detailed history of Raymond James & Associates transactions in 23and Me Holding Co. stock. As of the latest transaction made, Raymond James & Associates holds 75,614 shares of ME stock, worth $373,533. This represents 0.0% of its overall portfolio holdings.

Number of Shares
75,614
Previous 75,614 -0.0%
Holding current value
$373,533
Previous $29,000 10.34%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024
SELL
$0.36 - $0.61 $3,600 - $6,100
-10,000 Reduced 11.68%
75,614 $29,000
Q1 2024

Apr 22, 2024
BUY
$0.4 - $0.91 $7,856 - $17,873
19,641 Added 29.77%
85,614 $45,000
Q4 2023

Jan 16, 2024
BUY
$0.71 - $0.97 $21,158 - $28,906
29,800 Added 82.38%
65,973 $60,000
Q3 2023

Oct 24, 2023
BUY
$0.96 - $2.01 $18,463 - $38,658
19,233 Added 113.54%
36,173 $35,000
Q2 2023

Jul 25, 2023
BUY
$1.59 - $2.29 $8,104 - $11,672
5,097 Added 43.04%
16,940 $29,000
Q1 2023

Apr 14, 2023
BUY
$2.05 - $2.87 $776 - $1,087
379 Added 3.31%
11,843 $27,000
Q4 2022

Feb 08, 2023
SELL
$2.06 - $3.47 $18,583 - $31,302
-9,021 Reduced 44.04%
11,464 $24,000
Q3 2022

Oct 25, 2022
BUY
$2.6 - $5.12 $16,341 - $32,179
6,285 Added 44.26%
20,485 $59,000
Q2 2022

Aug 12, 2022
SELL
$2.19 - $3.98 $57,115 - $103,798
-26,080 Reduced 64.75%
14,200 $35,000
Q1 2022

May 11, 2022
BUY
$3.28 - $7.12 $12,637 - $27,433
3,853 Added 10.58%
40,280 $154,000
Q4 2021

Feb 08, 2022
BUY
$6.55 - $13.25 $134,746 - $272,579
20,572 Added 129.75%
36,427 $243,000
Q3 2021

Nov 02, 2021
SELL
$7.29 - $11.0 $45,125 - $68,090
-6,190 Reduced 28.08%
15,855 $144,000
Q2 2021

Aug 11, 2021
BUY
$9.87 - $13.32 $217,584 - $293,639
22,045 New
22,045 $258,000

Others Institutions Holding ME

# of Institutions
14
Shares Held
7.41M
Call Options Held
0
Put Options Held
50K
View Full List

About 23andMe Holding Co.

ME Quotes by TradingView
  • Ticker ME
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 259,768,000
  • Market Cap $1.28B
  • Description
  • 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...
More about ME
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email